Tom B.
CEO
Mitrix.bio
Country or State
United States
Bio
'What if we could give a 90-year-old the mitochondria they had at 30?'' Sounds like Star Trek, but in fact, our researchers are on track to answer this question in the next few years. With teams at Stanford, UConn, and other universities in the US and Canada, we are creating what think could be a breakthrough in Longevity science - a new category of regenerative medicine that could impact Alzheimer's, AMD, liver disease, and perhaps aging itself.